Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 498
interventional 299
Observational 172
Registry 27

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 184
Drug|placebo 33
Device 21
Other 18
Behavioral 13
Procedure 6
Device|Drug 5
Drug|Other 4
Genetic|Other 3
Biological 2
Drug|Procedure 2
Behavioral|Other 1
Biological|Drug 1
Biological|Genetic 1
Device|Other 1
Diagnostic Test 1
Diagnostic Test|Drug 1
Drug|Genetic 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 77
Canada 26
France 19
NA 14
Japan 13
Italy 12
China 10
Korea, Republic of 5
Switzerland 5
United States|Canada 5
United Kingdom 4
Germany 3
Saudi Arabia 3
Brazil 2
Finland 2
Hong Kong 2
Japan|Taiwan 2
Russian Federation 2
Sweden 2
Turkey 2
NA 1
Argentina|Bulgaria|Chile|Colombia|Czech Republic|Denmark|Finland|Mexico|Norway|Poland|Romania|Russian Federation|Sweden|Turkey 1
Argentina|Bulgaria|Chile|Colombia|Denmark|Finland|Greece|Malaysia|Mexico|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Sweden|Taiwan|Thailand|Turkey 1
Argentina|United States|Australia|Austria|Belgium|Brazil|Canada|Czech Republic|Denmark|France|Germany|Greece|Hungary|India|Israel|Italy|Mexico|Netherlands|New Zealand|Norway|Portugal|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
Australia|Austria|Belgium|Czech Republic|Denmark|Finland|France|Germany|Hungary|Italy|Netherlands|Norway|Poland|South Africa|Spain|Sweden 1
Australia|Austria|Belgium|Czech Republic|Denmark|Finland|France|Germany|Hungary|Italy|Netherlands|Poland|South Africa|Spain|Sweden 1
Australia|Canada 1
Australia|Germany|Mexico|Spain|United Kingdom 1
Austria|Belgium|Bulgaria|Hungary|Latvia|Netherlands|Poland|Russian Federation|Ukraine 1
Austria|Belgium|Canada|China|Colombia|Czech Republic|Denmark|France|Germany|Israel|Italy|Mexico|Netherlands|Norway|Peru|Poland|South Africa|Spain|Sweden 1
Austria|Belgium|Denmark|France|Germany|Israel|Italy|Netherlands|Norway|Poland|Spain|Sweden|United Kingdom 1
Austria|Bosnia and Herzegovina|Czech Republic|Denmark|Finland|Germany|Greece|Italy|Latvia|Lithuania|Norway|Poland|Russian Federation|Serbia|Slovakia|Spain|Sweden 1
Austria|Canada|Czechia|Finland|Netherlands|Sweden 1
Austria|France|Germany|Israel|Italy|Spain|Turkey 1
Austria|Germany|Netherlands 1
Belgium|Austria|Czech Republic|Denmark|Finland|France|Hungary|Italy|Netherlands|Norway|South Africa|Sweden 1
Belgium|United States|Argentina|Australia|Austria|Brazil|Canada|China|Finland|France|Germany|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Mexico|Netherlands|Portugal|Russian Federation|Singapore|Slovakia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Bulgaria|Canada|Latvia|Russian Federation|Ukraine 1
Bulgaria|Israel|Latvia|Poland|Romania|Russian Federation|Ukraine 1
Bulgaria|Latvia|Lithuania|Poland|Ukraine 1
Canada|France|Russian Federation 1
Canada|India 1
Canada|Italy|Lithuania|Russian Federation|Switzerland|Thailand 1
Canada|Netherlands|Switzerland 1
Canada|New Zealand 1
Canada|Norway 1
Colombia 1
Czech Republic|Denmark|Norway|Sweden 1
Czechia|Bulgaria|Canada|Greece|Israel|Latvia|Lithuania|Poland|Portugal|Russian Federation|South Africa|Spain|Ukraine 1
Denmark 1
Denmark|Austria|Belgium|France|Germany|Israel|Netherlands|Norway|Poland|Sweden|United Kingdom 1
Denmark|United States|Australia|Austria|Bosnia and Herzegovina|Brazil|Canada|Colombia|Czech Republic|Estonia|Finland|Germany|Hungary|India|Israel|Italy|Latvia|Lithuania|Norway|Poland|Puerto Rico|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Ukraine|United Kingdom 1
France|Finland|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Colombia|Czech Republic|Denmark|Germany|Greece|Hungary|Israel|Italy|Lithuania|Mexico|Netherlands|Norway|Poland|Slovakia|South Africa|Spain|Sweden|Turkey 1
France|Germany|India|Italy|Netherlands|Poland|Portugal|Russian Federation|Spain 1
France|Monaco 1
France|Romania|Ukraine|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|Estonia|Finland|Georgia|Germany|Hungary|Israel|Italy|Latvia|Lithuania|Montserrat|Peru|Poland|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|United Kingdom 1
France|Spain|Sweden|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czech Republic|Denmark|Estonia|Finland|Germany|Greece|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Luxembourg|Malaysia|Mexico|Netherlands|New Zealand|Norway|Pakistan|Peru|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|Slovenia|South Africa|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
France|Switzerland 1
France|United States|Belgium|Brazil|Bulgaria|Canada|Czechia|Germany|Russian Federation|United Kingdom 1
Greece|Netherlands 1
Iceland 1
Indonesia|Japan|Korea, Republic of|Malaysia|Philippines|Singapore|Taiwan|Thailand 1
Iraq 1
Israel 1
Israel|Italy|United States|Belgium|France|Germany|Netherlands|Poland|Portugal|Spain|United Kingdom 1
Japan|Korea, Republic of|Taiwan|Thailand 1
Japan|Taiwan|Thailand 1
Lebanon 1
Malaysia 1
Netherlands 1
Portugal|Romania|Russian Federation|Spain 1
Spain 1
Spain|Austria|Belgium|Denmark|France|Germany|Israel|Italy|Netherlands|Norway|Poland|Sweden|United Kingdom 1
Sweden|United Kingdom 1
Tunisia 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czech Republic|Denmark|Estonia|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Indonesia|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Peru|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Chile|China|Croatia|Czech Republic|Denmark|Estonia|Germany|Greece|Hungary|India|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|New Zealand|Norway|Peru|Poland|Romania|Russian Federation|Serbia|Slovakia|Slovenia|South Africa|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Canada|Chile|China|Czechia|Denmark|Estonia|France|Germany|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Greece|Hungary|India|Israel|Italy|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Colombia|France|Germany|India|Israel|Italy|Mexico|Poland|Russian Federation|South Africa|Spain|Tunisia|United Kingdom 1
United States|Argentina|Australia|Belarus|Canada|Chile|Colombia|Czech Republic|Denmark|Estonia|Finland|Germany|Greece|India|Italy|Mexico|Norway|Peru|Philippines|Poland|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|Ukraine 1
United States|Argentina|Australia|Belarus|Canada|Colombia|Czech Republic|Denmark|Estonia|Greece|Lithuania|Mexico|Poland|Romania|Russian Federation|South Africa|Ukraine 1
United States|Argentina|Austria|Belgium|Brazil|Canada|Czechia|Denmark|Finland|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Mexico|Norway|Russian Federation|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine 1
United States|Argentina|Belarus|Bulgaria|Canada|Chile|China|Colombia|Czech Republic|Denmark|Finland|Greece|India|Italy|Mexico|Peru|Poland|Portugal|Romania|Russian Federation|South Africa|Spain|Sweden|Turkey|Ukraine 1
United States|Argentina|Brazil|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|El Salvador|France|Germany|Guatemala|Hungary|India|Israel|Kenya|Korea, Republic of|Lebanon|Malaysia|Netherlands|Norway|Panama|Portugal|Russian Federation|Serbia|Singapore|Slovenia|Spain|Taiwan|Thailand|Turkey|Ukraine 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Korea, Republic of|Malaysia|Netherlands|New Zealand|Norway|Philippines|Poland|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom|Vietnam 1
United States|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|Finland|Germany|Hungary|India|Italy|Netherlands|New Zealand|Norway|Poland|South Africa|Spain|Sweden 1
United States|Australia|Austria|Belgium|Canada|Czech Republic|Estonia|Germany|Italy|Korea, Republic of|Latvia|Lithuania|Netherlands|New Zealand|Poland|Russian Federation|Singapore|South Africa|Sweden|Switzerland|Thailand 1
United States|Australia|Austria|Brazil|Canada|Colombia|Czech Republic|India|Israel|Italy|Korea, Republic of|Mexico|Poland|South Africa|Turkey 1
United States|Australia|Austria|Brazil|Canada|Hungary|Israel|Italy|Japan|Netherlands|Poland|Russian Federation|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Canada|Germany|Israel|Portugal|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Australia|Belgium|Canada|France|India|Switzerland 1
United States|Australia|Brazil|Bulgaria|Canada|China|Czech Republic|Denmark|France|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Brazil|Canada|China|Colombia|Denmark|Estonia|India|Indonesia|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|New Zealand|Norway|Peru|Portugal|South Africa|Sweden|Taiwan|United Kingdom 1
United States|Australia|Brazil|Canada|Czech Republic|Denmark|France|Israel|Italy|Netherlands|Poland|South Africa|Sweden 1
United States|Australia|Brazil|Canada|India|Israel|Latvia|Lithuania|Poland|Russian Federation|South Africa|Ukraine|United Kingdom 1
United States|Australia|Brazil|Canada|Saudi Arabia|United Kingdom 1
United States|Australia|Canada|Israel|Mexico 1
United States|Australia|Canada|Italy 1
United States|Austria|Belgium|Brazil|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Lithuania|Mexico|Norway|Russian Federation|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine 1
United States|Belarus|Belgium|Bosnia and Herzegovina|Canada|Chile|Latvia|Mexico|Moldova, Republic of|Russian Federation|Slovakia|Ukraine 1
United States|Belarus|Canada|Chile|China|Colombia|Egypt|India|Korea, Republic of|Lithuania|Mexico|Peru|Russian Federation|South Africa|Turkey|Ukraine 1
United States|Belgium|Canada|Czechia|Denmark|Germany|Hungary|Italy|Netherlands|Norway|Spain|Switzerland|United Kingdom 1
United States|Belgium|France|Hungary|Italy|Netherlands 1
United States|Bulgaria|Canada|Denmark|India|Israel|Lithuania|Mexico|Norway|Pakistan|Poland|Sri Lanka|Sweden 1
United States|Canada|France|India|Italy|Jordan|Lebanon|Spain|Turkey|United Kingdom 1
United States|Canada|Mexico|United Kingdom 1
United States|Norway|Russian Federation|Slovenia|Spain 1

Sites per Study

Site_count Study_Count
1 137
2 21
3 5
4 5
5 6
6 4
7 4
8 7
9 4
10 4
11 2
13 2
14 6
15 3
16 4
17 3
18 4
19 2
20 2
21 4
22 2
23 2
25 1
26 1
27 2
29 1
30 1
31 3
32 1
33 1
35 2
36 3
37 1
38 2
39 2
41 2
46 1
54 2
56 1
59 1
61 1
62 2
64 1
65 1
67 1
78 1
79 1
91 1
94 1
101 1
105 1
108 1
109 1
116 1
124 1
126 1
127 1
130 1
132 1
135 1
139 1
143 1
147 1
151 1
156 1
158 1
215 1
220 1
250 1
267 1
270 1
275 1
322 1
411 1
454 1
463 1
676 1

Phase

Phase Study_Count
Phase 3 96
N/A 60
Phase 4 59
Phase 2 55
Phase 1 14
Phase 2/Phase 3 10
Early Phase 1 3
Phase 1/Phase 2 2

Number of Arms

Number_of_Arms Count_of_Studies
1 51
2 164
3 23
4 16
5 5
6 8
7 2
8 2
10 1
NA 27

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20 12.00 8.00000 10 8.0000 11.0 20.000 10.0000
1st Qu. 20 100.00 14.75000 33 130.0000 53.5 207.000 100.0000
Median 20 220.00 44.00000 56 289.0000 237.0 716.000 229.0000
Mean 52 26020.65 51.85714 56 396.2264 673.5 1661.558 668.6897
3rd Qu. 68 1000.00 78.00000 79 575.0000 970.0 2078.000 605.0000
Max. 116 1260576.00 129.00000 102 1973.0000 2415.0 20078.000 5000.0000

Trial Group Type

group_type Group_Count
Experimental 350
Active Comparator 186
No Intervention 41
Placebo Comparator 32
NA 27
Other 16

Intervention Model

intervention_model Study_Count
Parallel Assignment 215
Single Group Assignment 58
Crossover Assignment 10
NA 8
Factorial Assignment 4
Sequential Assignment 4

Primary Purpose

primary_purpose Study_Count
Prevention 153
Treatment 95
Diagnostic 13
Other 11
Health Services Research 7
NA 7
Supportive Care 6
Basic Science 4
Screening 3

Observational Studies

Studies by Country

Country Study_Count
NA 29
United States 28
France 26
Germany 10
Sweden 7
Denmark 6
Switzerland 6
Italy 5
Korea, Republic of 5
Spain 5
Netherlands 4
Canada 3
United Kingdom 3
Argentina 2
Australia 2
China 2
Norway 2
Taiwan 2
Algeria|Egypt|Indonesia|Jordan|Kazakhstan|Kenya|Korea, Republic of|Kuwait|Lebanon|Malaysia|Mexico|Morocco|Philippines|Qatar|Russian Federation|Saudi Arabia|Singapore|Taiwan|Turkey|Ukraine|United Arab Emirates 1
Argentina|Canada|Chile|Germany|Italy|Spain 1
Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Cyprus|Czech Republic|Denmark|Estonia|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Italy|Korea, Republic of|Latvia|Lebanon|Lithuania|Macedonia, The Former Yugoslav Republic of|Mexico|Netherlands|Norway|Philippines|Portugal|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|United Arab Emirates|United Kingdom|Venezuela|Vietnam 1
Australia|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Moldova, Republic of|Netherlands|Norway|Portugal|Slovenia|Spain|Sweden|Switzerland|Ukraine|United Kingdom 1
Austria|France|Germany|Ireland|Italy|Poland|Spain|Sweden|United Kingdom 1
Austria|France|Germany|Italy|Spain|Sweden|United Kingdom 1
Belgium|Canada|Germany|Italy|Netherlands|Spain 1
Canada|Netherlands|Switzerland 1
Greece 1
India 1
Ireland 1
Japan 1
Korea, Republic of|Taiwan 1
Portugal 1
Russian Federation 1
Turkey 1
United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Czechia|Egypt|Germany|Greece|Hungary|Italy|Korea, Republic of|Latvia|Lebanon|Malaysia|Mexico|Netherlands|New Zealand|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Slovenia|Thailand|Turkey|United Arab Emirates|United Kingdom|Vietnam 1
United States|Belgium|France|Italy|Spain 1
United States|Canada 1
United States|Canada|China 1
United States|Canada|France|Italy|Spain 1
United States|Canada|United Kingdom 1
United States|Germany|Switzerland 1
United States|Spain 1

Sites per Study

Site_count Study_Count
1 123
2 7
3 7
4 2
5 3
6 3
7 2
8 1
9 4
10 1
12 1
14 1
18 1
19 2
20 1
21 2
23 3
28 1
35 1
42 1
49 1
53 2
112 1
222 1

Enrollment Metrics

Measure Observational
Min 5.00
1st Qu 123.00
Median 464.00
Mean 10865.08
3rd Qu 2537.00
Max 598682.00

Observation Model

observational_model Study_Count
Cohort 120
NA 17
Case-Only 12
Case Control 12
Case-Control 6
Other 4
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 110
Retrospective 42
NA 9
Cross-Sectional 8
Other 3

Registries

Studies by Country

Country Study_Count
United States 5
NA 4
China 3
Greece 2
Spain 2
Australia|Belgium|Chile|Denmark|Finland|France|Germany|Ireland|Israel|Italy|Netherlands|Norway|Poland|Spain|Sweden|United Kingdom 1
Austria 1
Belgium 1
Belgium|France|Germany|Ireland|Italy|Netherlands|Poland|Portugal|Russian Federation|Saudi Arabia|Spain|United Arab Emirates|United Kingdom 1
Canada 1
Germany 1
Israel 1
Italy 1
Korea, Republic of 1
Poland 1
Russian Federation 1

Sites per Study

Site_count Study_Count
1 20
3 1
4 1
8 1
10 1
21 1
47 1
51 1

Enrollment Metrics

Measure Registries
Min 29.00
1st Qu 325.50
Median 1000.00
Mean 38954.44
3rd Qu 3027.00
Max 902891.00

Registry Model

observational_model Study_Count
Cohort 20
Other 4
Case-Only 3

Time Perspective

time_perspective Study_Count
Prospective 25
Other 2

Follow-up

target_duration Study_Count
2 Years 5
3 Years 5
1 Day 2
1 Year 2
12 Months 2
6 Months 2
1 Month 1
10 Months 1
2 Weeks 1
24 Months 1
3 Months 1
30 Days 1
4 Months 1
4 Weeks 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03244020 Low Molecular Weight Heparin (LMWH) vs Aspirin for Venous Thromboembolism (VTE) Prophylaxis in Orthopaedic Oncology https://ClinicalTrials.gov/show/NCT03244020 Enrolling by invitation Massachusetts General Hospital 2023-12-31
NCT04263038 Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04263038 Recruiting University Hospital Inselspital, Berne 2024-02-29
NCT03339349 Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma https://ClinicalTrials.gov/show/NCT03339349 Completed University of Utah 2019-06-30
NCT03826043 THrombo-Embolic Event in Onco-hematology https://ClinicalTrials.gov/show/NCT03826043 Recruiting Centre Antoine Lacassagne 2022-03-08
NCT03297359 WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03297359 Recruiting Ottawa Hospital Research Institute 2022-12-31
NCT03285438 REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. https://ClinicalTrials.gov/show/NCT03285438 Recruiting University Hospital, Brest 2022-10-09
NCT03276143 FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty https://ClinicalTrials.gov/show/NCT03276143 Completed Bayer 2018-08-20
NCT03266783 Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03266783 Recruiting Ottawa Hospital Research Institute 2023-06-30
NCT03259204 Swedish Multicenter Trial of Outpatient Prevention of Leg Clots https://ClinicalTrials.gov/show/NCT03259204 Recruiting Karolinska University Hospital 2020-12-31
NCT03243708 Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients https://ClinicalTrials.gov/show/NCT03243708 Completed The Cleveland Clinic 2019-04-14
NCT03212365 Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery https://ClinicalTrials.gov/show/NCT03212365 Completed University of Utah 2019-06-02
NCT03197792 Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy https://ClinicalTrials.gov/show/NCT03197792 Recruiting Centre Chirurgical Marie Lannelongue 2018-05-24
NCT03185845 The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism https://ClinicalTrials.gov/show/NCT03185845 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-12-31
NCT03183063 Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events https://ClinicalTrials.gov/show/NCT03183063 Completed William Beaumont Hospitals 2019-04-23
NCT03158792 Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function https://ClinicalTrials.gov/show/NCT03158792 Completed Lebanese American University 2017-07-13
NCT03129555 The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) https://ClinicalTrials.gov/show/NCT03129555 Recruiting Danish Heart Foundation 2020-03-31
NCT03124017 Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients https://ClinicalTrials.gov/show/NCT03124017 Completed University Hospital Inselspital, Berne 2016-03-31
NCT03090880 Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) https://ClinicalTrials.gov/show/NCT03090880 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-31
NCT03088358 Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement https://ClinicalTrials.gov/show/NCT03088358 Completed TeaRx LLC 2015-09-30
NCT03083782 Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus https://ClinicalTrials.gov/show/NCT03083782 Completed Thomas Jefferson University 2017-06-05
NCT03070834 RIPT Feasibility Trial https://ClinicalTrials.gov/show/NCT03070834 Recruiting Lawson Health Research Institute 2020-02-16
NCT03251963 Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients https://ClinicalTrials.gov/show/NCT03251963 Completed University of Utah 2019-03-27
NCT03055026 Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer. https://ClinicalTrials.gov/show/NCT03055026 Recruiting Fadoi Foundation, Italy 2020-12-31
NCT03044574 Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03044574 Completed Pirogov Russian National Research Medical University 2018-09-30
NCT02978950 SToP: Venous Thromboembolism Screening in the Trauma Population https://ClinicalTrials.gov/show/NCT02978950 Recruiting Intermountain Health Care, Inc. 2019-12-31
NCT02970032 Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin https://ClinicalTrials.gov/show/NCT02970032 Completed University of Utah 2017-09-10
NCT02969343 Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered https://ClinicalTrials.gov/show/NCT02969343 Completed Brigham and Women’s Hospital 2018-12-31
NCT02958969 Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma https://ClinicalTrials.gov/show/NCT02958969 Completed Dana-Farber Cancer Institute 2019-06-30
NCT02945280 Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT02945280 Recruiting Intermountain Health Care, Inc. 2023-12-31
NCT02935530 Thromboprophylaxis After Surgery for Gynecologic Malignancy in China https://ClinicalTrials.gov/show/NCT02935530 Completed Huazhong University of Science and Technology 2017-08-31
NCT02912234 Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants https://ClinicalTrials.gov/show/NCT02912234 Completed Bristol-Myers Squibb 2016-10-31
NCT02901067 STAT-STatin and Aspirin in Trauma https://ClinicalTrials.gov/show/NCT02901067 Recruiting Denver Health and Hospital Authority 2021-12-31
NCT02870296 Anticoagulation Medical Home https://ClinicalTrials.gov/show/NCT02870296 Completed University of Massachusetts, Worcester 2017-11-03
NCT02864810 Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism https://ClinicalTrials.gov/show/NCT02864810 Completed Asan Foundation 2017-09-09
NCT02864537 Self-management of Anticoagulation Treatment https://ClinicalTrials.gov/show/NCT02864537 Completed University of Bergen 2013-03-31
NCT02853188 Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung https://ClinicalTrials.gov/show/NCT02853188 Completed Hopital Foch 2018-12-20
NCT02832947 PK of Rivaroxaban in Bariatric Patients - Extension https://ClinicalTrials.gov/show/NCT02832947 Completed University Hospital Inselspital, Berne 2016-06-30
NCT02829957 RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding https://ClinicalTrials.gov/show/NCT02829957 Recruiting Indiana University 2025-12-31
NCT02798471 Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT02798471 Recruiting Daiichi Sankyo, Inc. 2020-12-31
NCT02795065 Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients https://ClinicalTrials.gov/show/NCT02795065 Completed Al Mouwasat Hospital 2016-03-31
NCT02785757 Cancer-related Thromboembolic Disease https://ClinicalTrials.gov/show/NCT02785757 Recruiting Hospices Civils de Lyon 2022-02-12
NCT02779400 Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) Measurement https://ClinicalTrials.gov/show/NCT02779400 Completed University Hospital, Grenoble 2018-04-14
NCT02774265 A Different Approach to Preventing Thrombosis https://ClinicalTrials.gov/show/NCT02774265 Completed University of Maryland, Baltimore 2017-05-31
NCT02746185 Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban https://ClinicalTrials.gov/show/NCT02746185 Completed Assistance Publique - Hôpitaux de Paris 2018-04-25
NCT02744092 Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer https://ClinicalTrials.gov/show/NCT02744092 Active, not recruiting Alliance Foundation Trials, LLC. 2020-06-30
NCT02704052 Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose https://ClinicalTrials.gov/show/NCT02704052 Completed University of Utah 2018-07-31
NCT02687204 Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients https://ClinicalTrials.gov/show/NCT02687204 Completed University of Utah 2017-06-23
NCT02679664 StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study https://ClinicalTrials.gov/show/NCT02679664 Active, not recruiting Ottawa Hospital Research Institute 2020-01-13
NCT02664155 Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants https://ClinicalTrials.gov/show/NCT02664155 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2020-12-31
NCT02616991 Computed Tomography CT Venography During Postpartum Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02616991 Recruiting Assistance Publique - Hôpitaux de Paris 2020-03-31
NCT02585713 Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02585713 Completed Academic and Community Cancer Research United 2018-04-02
NCT02583191 Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients https://ClinicalTrials.gov/show/NCT02583191 Recruiting AIO-Studien-gGmbH 2019-12-31
NCT01895777 Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT01895777 Completed Boehringer Ingelheim 2019-10-16
NCT02564718 Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates https://ClinicalTrials.gov/show/NCT02564718 Completed Bayer 2017-12-18
NCT02559856 Comparison of Bleeding Risk Between Rivaroxaban and Apixaban https://ClinicalTrials.gov/show/NCT02559856 Completed Ottawa Hospital Research Institute 2017-11-30
NCT02555878 A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants https://ClinicalTrials.gov/show/NCT02555878 Completed Janssen Research & Development, LLC 2018-08-24
NCT02486666 Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose https://ClinicalTrials.gov/show/NCT02486666 Recruiting Hamilton Health Sciences Corporation 2020-12-31
NCT02474212 : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery https://ClinicalTrials.gov/show/NCT02474212 Recruiting Tampere University Hospital 2020-12-31
NCT02464969 Apixaban for the Acute Treatment of Venous Thromboembolism in Children https://ClinicalTrials.gov/show/NCT02464969 Recruiting Pfizer 2023-04-30
NCT02444572 Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® https://ClinicalTrials.gov/show/NCT02444572 Recruiting Les Laboratoires des Médicaments Stériles 2020-12-31
NCT02438098 Rivaroxaban in Bariatric Surgery https://ClinicalTrials.gov/show/NCT02438098 Completed University Hospital Inselspital, Berne 2015-11-30
NCT02425345 Women’s Health Initiative Strong and Healthy Study https://ClinicalTrials.gov/show/NCT02425345 Active, not recruiting Fred Hutchinson Cancer Research Center 2020-12-31
NCT02412982 Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients https://ClinicalTrials.gov/show/NCT02412982 Recruiting University of Cincinnati 2018-12-31
NCT02411292 Enoxaparin Metabolism in Reconstructive Surgery Patients https://ClinicalTrials.gov/show/NCT02411292 Completed University of Utah 2016-03-31
NCT02402881 Education Bundle to Decrease Patient Refusal of VTE Prophylaxis https://ClinicalTrials.gov/show/NCT02402881 Completed Johns Hopkins University 2018-11-30
NCT02379806 The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study https://ClinicalTrials.gov/show/NCT02379806 Recruiting University Hospital, Brest 2022-12-31
NCT02376803 The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The “INRange” RCT https://ClinicalTrials.gov/show/NCT02376803 Completed University of Alberta 2016-09-30
NCT02366871 Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy https://ClinicalTrials.gov/show/NCT02366871 Completed University of Colorado, Denver 2019-06-30
NCT02342444 Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) https://ClinicalTrials.gov/show/NCT02342444 Recruiting Oregon Health and Science University 2020-12-31
NCT02334007 Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery https://ClinicalTrials.gov/show/NCT02334007 Completed McMaster University 2018-09-30
NCT02309411 EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis https://ClinicalTrials.gov/show/NCT02309411 Completed Bayer 2017-04-05
NCT02303431 Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study https://ClinicalTrials.gov/show/NCT02303431 Recruiting Daiichi Sankyo, Inc. 2020-09-30
NCT02301793 Educating Nurses About Venous Thromboembolism (VTE) Prevention https://ClinicalTrials.gov/show/NCT02301793 Completed Johns Hopkins University 2015-03-31
NCT02295475 Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome https://ClinicalTrials.gov/show/NCT02295475 Active, not recruiting Intermountain Health Care, Inc. 2021-04-30
NCT02271399 Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty https://ClinicalTrials.gov/show/NCT02271399 Completed Hanyang University Seoul Hospital 2016-01-31
NCT02234843 EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis https://ClinicalTrials.gov/show/NCT02234843 Completed Bayer 2019-01-30
NCT02223260 Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age https://ClinicalTrials.gov/show/NCT02223260 Completed Boehringer Ingelheim 2016-01-31
NCT02197416 Safety of Dabigatran Etexilate in Blood Clot Prevention in Children https://ClinicalTrials.gov/show/NCT02197416 Completed Boehringer Ingelheim 2019-10-16
NCT02195232 Cancer Associated Thrombosis and Isoquercetin (CATIQ) https://ClinicalTrials.gov/show/NCT02195232 Active, not recruiting Dana-Farber Cancer Institute 2018-12-31
NCT02186223 The Angel® Catheter Pivotal Clinical Trial https://ClinicalTrials.gov/show/NCT02186223 Completed BiO2 Medical 2015-12-31
NCT02170935 Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery https://ClinicalTrials.gov/show/NCT02170935 Completed Boehringer Ingelheim 2002-06-30
NCT02170701 BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery https://ClinicalTrials.gov/show/NCT02170701 Completed Boehringer Ingelheim 2001-06-30
NCT02103101 Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events https://ClinicalTrials.gov/show/NCT02103101 Completed Centre Hospitalier Universitaire de Besancon 2017-10-31
NCT02095509 Pharmacokinetics of Enoxaparin in Intensive Care Patients https://ClinicalTrials.gov/show/NCT02095509 Completed Tampere University Hospital 2016-06-30
NCT02073682 Cancer Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT02073682 Completed Daiichi Sankyo, Inc. 2017-09-15
NCT02070237 Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis https://ClinicalTrials.gov/show/NCT02070237 Completed MemorialCare Health System 2014-03-31
NCT02067182 Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation https://ClinicalTrials.gov/show/NCT02067182 Recruiting University Hospital, Bonn 2020-08-31
NCT02064439 Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) https://ClinicalTrials.gov/show/NCT02064439 Completed Bayer 2016-09-22
NCT01317160 Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture https://ClinicalTrials.gov/show/NCT01317160 Completed Karolinska University Hospital 2015-08-31
NCT01308528 Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery https://ClinicalTrials.gov/show/NCT01308528 Completed Cristália Produtos Químicos Farmacêuticos Ltda. 2017-02-28
NCT01274637 PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot https://ClinicalTrials.gov/show/NCT01274637 Completed Ottawa Hospital Research Institute 2014-01-31
NCT02048865 Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients https://ClinicalTrials.gov/show/NCT02048865 Completed Ottawa Hospital Research Institute 2018-10-10
NCT01989845 Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer https://ClinicalTrials.gov/show/NCT01989845 Completed Seoul National University Hospital 2016-12-31
NCT01976988 Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery https://ClinicalTrials.gov/show/NCT01976988 Completed Cedars-Sinai Medical Center 2015-05-31
NCT01976507 Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism https://ClinicalTrials.gov/show/NCT01976507 Completed Vanderbilt University Medical Center 2016-12-31
NCT01938248 Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation https://ClinicalTrials.gov/show/NCT01938248 Recruiting Population Health Research Institute 2022-08-31
NCT01935414 Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study https://ClinicalTrials.gov/show/NCT01935414 Active, not recruiting Firstkind Ltd 2016-11-16
NCT01924065 Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation https://ClinicalTrials.gov/show/NCT01924065 Active, not recruiting Suleyman Demirel University 2017-08-31
NCT01869075 Toronto Thromboprophylaxis Patient Safety Initiative https://ClinicalTrials.gov/show/NCT01869075 Completed Sunnybrook Health Sciences Centre 2009-03-31
NCT01857583 Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs https://ClinicalTrials.gov/show/NCT01857583 Completed Daiichi Sankyo, Inc. 2012-12-31
NCT01835990 Feasibility Study of Geko vs. IPCs in Trauma https://ClinicalTrials.gov/show/NCT01835990 Completed Hamilton Health Sciences Corporation 2014-08-31
NCT01747746 Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study https://ClinicalTrials.gov/show/NCT01747746 Completed John H. Stroger Hospital 2014-10-31
NCT01729559 Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin https://ClinicalTrials.gov/show/NCT01729559 Completed Scripps Health 2014-09-30
NCT01727401 Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia https://ClinicalTrials.gov/show/NCT01727401 Active, not recruiting G. d’Annunzio University 2020-12-31
NCT01720108 Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty https://ClinicalTrials.gov/show/NCT01720108 Completed Nova Scotia Health Authority 2016-07-31
NCT01713361 Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplasty https://ClinicalTrials.gov/show/NCT01713361 Completed Ionis Pharmaceuticals, Inc. 2014-05-31
NCT01707394 Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder https://ClinicalTrials.gov/show/NCT01707394 Recruiting Bristol-Myers Squibb 2021-05-31
NCT01696760 Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology https://ClinicalTrials.gov/show/NCT01696760 Completed Ohio State University Comprehensive Cancer Center 2012-12-31
NCT01653405 Improving Anticoagulation Control in VISN 1 https://ClinicalTrials.gov/show/NCT01653405 Completed VA Office of Research and Development 2016-09-30
NCT01598805 Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts https://ClinicalTrials.gov/show/NCT01598805 Completed University of Zurich 2012-09-30
NCT01588171 Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum https://ClinicalTrials.gov/show/NCT01588171 Completed Hawler Medical University 2013-10-31
NCT01583218 Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) https://ClinicalTrials.gov/show/NCT01583218 Completed Portola Pharmaceuticals 2015-12-31
NCT01573169 PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients https://ClinicalTrials.gov/show/NCT01573169 Recruiting University Of Perugia 2020-12-31
NCT01561885 Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways https://ClinicalTrials.gov/show/NCT01561885 Completed King Abdullah International Medical Research Center 2016-03-31
NCT01524653 Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) https://ClinicalTrials.gov/show/NCT01524653 Completed University of Vermont 2016-07-01
NCT01513759 Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy https://ClinicalTrials.gov/show/NCT01513759 Completed EKOS Corporation 2013-02-17
NCT01467583 Fondaparinux in Critically Ill Patients With Renal Failure https://ClinicalTrials.gov/show/NCT01467583 Completed Wayne State University 2013-11-30
NCT01463280 Effect of Tumescent Lidocaine on Platelet Function https://ClinicalTrials.gov/show/NCT01463280 Completed Klein, Jeffrey A., M.D. 2013-12-31
NCT01452568 Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin https://ClinicalTrials.gov/show/NCT01452568 Completed Rigshospitalet, Denmark 2012-03-31
NCT01431456 Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery https://ClinicalTrials.gov/show/NCT01431456 Completed Martini Hospital Groningen 2014-10-31
NCT01403090 Safety Study of the Angelâ„¢ Catheter in Subjects With Risk of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01403090 Completed BiO2 Medical 2012-03-31
NCT01401725 Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients https://ClinicalTrials.gov/show/NCT01401725 Completed McMaster University 2012-06-30
NCT01370278 Clearance Of Mucus In Stents (COMIS) https://ClinicalTrials.gov/show/NCT01370278 Active, not recruiting M.D. Anderson Cancer Center 2020-06-30
NCT01348074 Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist https://ClinicalTrials.gov/show/NCT01348074 Completed McMaster University 2013-12-31
NCT01344954 Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery https://ClinicalTrials.gov/show/NCT01344954 Completed ThromboGenics 2011-12-31
NCT04444700 A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04444700 Recruiting University of Sao Paulo General Hospital 2020-10-31
NCT04393909 Improving Safety of Diagnosis and Therapy in the Inpatient Setting https://ClinicalTrials.gov/show/NCT04393909 Recruiting Brigham and Women’s Hospital 2021-06-30
NCT04305756 Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery https://ClinicalTrials.gov/show/NCT04305756 Recruiting University of Utah 2021-07-01
NCT04267718 Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill Patients https://ClinicalTrials.gov/show/NCT04267718 Recruiting Fadoi Foundation, Italy 2020-04-30
NCT04169269 Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban https://ClinicalTrials.gov/show/NCT04169269 Recruiting Florida Orthopaedic Institute 2020-12-31
NCT04157881 A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers https://ClinicalTrials.gov/show/NCT04157881 Recruiting Population Health Research Institute 2020-04-30
NCT04141254 Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. https://ClinicalTrials.gov/show/NCT04141254 Recruiting University Hospital, Brest 2021-12-31
NCT04072068 Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy https://ClinicalTrials.gov/show/NCT04072068 Recruiting Gruppo Oncologico Italiano di Ricerca Clinica 2020-07-31
NCT04066764 Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters https://ClinicalTrials.gov/show/NCT04066764 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2024-10-01
NCT04041843 Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT04041843 Recruiting New York Medical College 2020-05-31
NCT04031859 Risk Stratification Procedure for Thromboembolism Prophylaxis https://ClinicalTrials.gov/show/NCT04031859 Completed Ministry of Health, Saudi Arabia 2019-07-14
NCT04022915 PET Fibrin Imaging of DVT and PE https://ClinicalTrials.gov/show/NCT04022915 Recruiting Massachusetts General Hospital 2023-05-13
NCT03988101 Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event https://ClinicalTrials.gov/show/NCT03988101 Recruiting Yonsei University 2021-02-28
NCT03919890 A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT03919890 Completed Ono Pharmaceutical Co. Ltd 2019-08-23
NCT03812328 Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement https://ClinicalTrials.gov/show/NCT03812328 Completed Tetherex Pharmaceuticals Corporation 2019-10-01
NCT03804697 Selective Thromboembolism Prophylaxis After Arthroplasty https://ClinicalTrials.gov/show/NCT03804697 Completed Guangdong Provincial People’s Hospital 2017-08-31
NCT03728166 Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) https://ClinicalTrials.gov/show/NCT03728166 Recruiting Brigham and Women’s Hospital 2020-11-30
NCT03691753 Safety and Efficacy Study of Fitaya Vena Cava Filter https://ClinicalTrials.gov/show/NCT03691753 Recruiting Lifetech Scientific (Shenzhen) Co., Ltd. 2020-04-30
NCT03678506 Apixaban for Extended Anticoagulation (APIDULCIS) https://ClinicalTrials.gov/show/NCT03678506 Recruiting Arianna Anticoagulazione Foundation 2021-02-28
NCT03636295 Low INR to Minimize Bleeding With Mechanical Valves Trial https://ClinicalTrials.gov/show/NCT03636295 Recruiting McMaster University 2022-09-30
NCT03581877 Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE https://ClinicalTrials.gov/show/NCT03581877 Recruiting Northwell Health 2021-12-31
NCT03559114 PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) https://ClinicalTrials.gov/show/NCT03559114 Recruiting Sunnybrook Health Sciences Centre 2022-12-31
NCT03516656 Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin https://ClinicalTrials.gov/show/NCT03516656 Active, not recruiting University of Utah 2019-06-30
NCT03424460 Venous Thromboembolism in Myotonic Dystrophy Type 1 https://ClinicalTrials.gov/show/NCT03424460 Recruiting Assistance Publique - Hôpitaux de Paris 2021-01-11
NCT01267305 The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery https://ClinicalTrials.gov/show/NCT01267305 Completed Shanghai Zhongshan Hospital 2013-04-30
NCT01234064 Graduated Compression Stockings (GCS) Pilot Substudy https://ClinicalTrials.gov/show/NCT01234064 Completed McMaster University 2011-12-31
NCT01225822 BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT01225822 Completed Boehringer Ingelheim 2003-08-31
NCT01210755 Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics https://ClinicalTrials.gov/show/NCT01210755 Completed University Hospital, Grenoble 2011-03-31
NCT01206972 Dose-confirmatory Bridging Study in Total Knee Replacement https://ClinicalTrials.gov/show/NCT01206972 Completed Bayer 2011-05-31
NCT01205932 Dose-confirmatory Bridging Study in Total Hip Replacement https://ClinicalTrials.gov/show/NCT01205932 Completed Bayer 2011-06-30
NCT01203098 A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty https://ClinicalTrials.gov/show/NCT01203098 Completed Daiichi Sankyo, Inc. 2008-12-31
NCT01203072 A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty https://ClinicalTrials.gov/show/NCT01203072 Completed Daiichi Sankyo, Inc. 2007-09-30
NCT01184989 Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate https://ClinicalTrials.gov/show/NCT01184989 Completed Boehringer Ingelheim 2013-04-30
NCT01181167 A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty https://ClinicalTrials.gov/show/NCT01181167 Completed Daiichi Sankyo, Inc. 2010-01-31
NCT01181141 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery https://ClinicalTrials.gov/show/NCT01181141 Completed Daiichi Sankyo, Inc. 2009-08-31
NCT01181102 A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty https://ClinicalTrials.gov/show/NCT01181102 Completed Daiichi Sankyo, Inc. 2009-09-30
NCT01130025 Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer https://ClinicalTrials.gov/show/NCT01130025 Completed LEO Pharma 2014-04-30
NCT01119300 EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin https://ClinicalTrials.gov/show/NCT01119300 Completed Utrecht Institute for Pharmaceutical Sciences 2013-10-31
NCT01119274 EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon https://ClinicalTrials.gov/show/NCT01119274 Completed Utrecht Institute for Pharmaceutical Sciences 2013-01-31
NCT01119261 EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol https://ClinicalTrials.gov/show/NCT01119261 Completed Utrecht Institute for Pharmaceutical Sciences 2013-06-30
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial https://ClinicalTrials.gov/show/NCT01118299 Completed Abbott Medical Devices 2018-12-06
NCT01094886 Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement https://ClinicalTrials.gov/show/NCT01094886 Completed Ortho-McNeil Janssen Scientific Affairs, LLC 2010-12-31
NCT01083732 Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age https://ClinicalTrials.gov/show/NCT01083732 Completed Boehringer Ingelheim 2016-02-29
NCT01068795 Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome https://ClinicalTrials.gov/show/NCT01068795 Completed HaEmek Medical Center, Israel 2015-01-31
NCT01050153 The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma https://ClinicalTrials.gov/show/NCT01050153 Completed Denver Health and Hospital Authority 2011-12-31
NCT01028950 YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness https://ClinicalTrials.gov/show/NCT01028950 Completed Astellas Pharma Inc 2010-04-30
NCT01006876 Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation https://ClinicalTrials.gov/show/NCT01006876 Completed Texas Cardiac Arrhythmia Research Foundation 2013-03-31
NCT01006733 Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT https://ClinicalTrials.gov/show/NCT01006733 Completed Washington University School of Medicine 2016-10-31
NCT00986154 Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). https://ClinicalTrials.gov/show/NCT00986154 Completed Daiichi Sankyo, Inc. 2013-04-30
NCT00981409 The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients https://ClinicalTrials.gov/show/NCT00981409 Completed GlaxoSmithKline 2008-12-31
NCT00978445 Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System https://ClinicalTrials.gov/show/NCT00978445 Completed ZIN Technologies, Inc. 2010-08-31
NCT00968929 Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC) https://ClinicalTrials.gov/show/NCT00968929 Completed Beijing Chao Yang Hospital 2009-05-31
NCT00967304 Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00967304 Completed Ottawa Hospital Research Institute 2015-01-31
NCT00966277 Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients https://ClinicalTrials.gov/show/NCT00966277 Completed M.D. Anderson Cancer Center 2014-09-30
NCT00964275 Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein https://ClinicalTrials.gov/show/NCT00964275 Completed University Hospital, Brest 2014-10-31
NCT00952380 Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients https://ClinicalTrials.gov/show/NCT00952380 Completed Pfizer 2018-03-31
NCT00951574 Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium) https://ClinicalTrials.gov/show/NCT00951574 Completed Italfarmaco 2007-05-31
NCT00942435 A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery https://ClinicalTrials.gov/show/NCT00942435 Completed Astellas Pharma Inc 2010-04-30
NCT00937911 Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities https://ClinicalTrials.gov/show/NCT00937911 Completed Astellas Pharma Inc 2010-04-30
NCT00937820 Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00937820 Completed Astellas Pharma Inc 2010-12-31
NCT00927862 Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin https://ClinicalTrials.gov/show/NCT00927862 Completed Intermountain Health Care, Inc. 2010-12-31
NCT00917254 Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00917254 Completed Astellas Pharma Inc 2010-01-31
NCT00913120 Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery https://ClinicalTrials.gov/show/NCT00913120 Completed Astellas Pharma Inc 2010-03-31
NCT00902928 A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery https://ClinicalTrials.gov/show/NCT00902928 Completed Astellas Pharma Inc 2010-06-30
NCT00878826 Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy. https://ClinicalTrials.gov/show/NCT00878826 Completed Stanford University 2011-08-31
NCT00853463 Discharge ALERT: Quality Improvement Initiative https://ClinicalTrials.gov/show/NCT00853463 Completed Brigham and Women’s Hospital 2010-03-31
NCT00851864 Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing https://ClinicalTrials.gov/show/NCT00851864 Completed University of Calgary 2010-10-31
NCT00844415 Safety and Tolerability of Dabigatran Etexilate in Adolescents https://ClinicalTrials.gov/show/NCT00844415 Completed Boehringer Ingelheim 2012-02-29
NCT00839826 ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial https://ClinicalTrials.gov/show/NCT00839826 Completed Bayer 2003-11-30
NCT03240120 A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03240120 Recruiting The University of Hong Kong 2021-05-31
NCT03045406 Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer https://ClinicalTrials.gov/show/NCT03045406 Active, not recruiting Fadoi Foundation, Italy 2019-06-01
NCT02913326 A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT) https://ClinicalTrials.gov/show/NCT02913326 Completed Boehringer Ingelheim 2018-06-22
NCT04367831 Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 https://ClinicalTrials.gov/show/NCT04367831 Recruiting Columbia University 2020-11-30
NCT03244267 App Reminder on ASA Adherence https://ClinicalTrials.gov/show/NCT03244267 Completed Emory University 2019-03-08
NCT04447378 Safety of Fondaparinux as Post Partum Thromboprophylaxis https://ClinicalTrials.gov/show/NCT04447378 Completed National University of Malaysia 2018-06-01
NCT00814177 Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients https://ClinicalTrials.gov/show/NCT00814177 Completed McMaster University 2009-01-31
NCT01565239 Fiix-prothrombin Time for Monitoring Warfarin https://ClinicalTrials.gov/show/NCT01565239 Completed Landspitali University Hospital 2014-02-28
NCT04257487 Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) https://ClinicalTrials.gov/show/NCT04257487 Recruiting Arianna Anticoagulazione Foundation 2023-09-02
NCT03139487 A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03139487 Recruiting Asan Medical Center 2021-09-30
NCT02040103 Pneumatic Compression for Preventing Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02040103 Completed King Abdullah International Medical Research Center 2018-11-13
NCT04373707 Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 https://ClinicalTrials.gov/show/NCT04373707 Recruiting Central Hospital, Nancy, France 2020-09-30
NCT00794560 Self-management of Low Molecular Weight Heparin Therapy https://ClinicalTrials.gov/show/NCT00794560 Completed University Hospital, Basel, Switzerland 2009-08-31
NCT00793234 Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00793234 Completed ThromboGenics 2010-01-31
NCT00790335 Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis https://ClinicalTrials.gov/show/NCT00790335 Completed Washington University School of Medicine 2017-01-31
NCT00786474 Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study) https://ClinicalTrials.gov/show/NCT00786474 Completed Duke University 2015-02-28
NCT00781378 Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China https://ClinicalTrials.gov/show/NCT00781378 Completed Beijing Chao Yang Hospital 2006-02-28
NCT00774748 Once Weekly Subcutaneous Ports for the Administration of Anticoagulants https://ClinicalTrials.gov/show/NCT00774748 Completed University of North Carolina, Chapel Hill 2010-04-30
NCT00773448 Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00773448 Completed Ottawa Hospital Research Institute 2015-04-30
NCT00740987 Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) https://ClinicalTrials.gov/show/NCT00740987 Completed University Hospital, Brest 2015-01-31
NCT00740844 Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) Patients With High Bleeding Risk https://ClinicalTrials.gov/show/NCT00740844 Completed University Hospital, Brest 2011-01-31
NCT00740493 Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP) https://ClinicalTrials.gov/show/NCT00740493 Completed University Hospital, Brest 2017-01-31
NCT00721760 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery https://ClinicalTrials.gov/show/NCT00721760 Completed Sanofi 2009-10-31
NCT00718224 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00718224 Completed Sanofi 2009-05-31
NCT00709904 Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery https://ClinicalTrials.gov/show/NCT00709904 Completed Sanofi 2010-01-31
NCT00703274 Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia https://ClinicalTrials.gov/show/NCT00703274 Completed Georgetown University 2013-01-31
NCT00680186 Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT00680186 Completed Boehringer Ingelheim 2011-05-31
NCT00697099 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery https://ClinicalTrials.gov/show/NCT00697099 Completed Sanofi 2009-06-30
NCT00694382 Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy https://ClinicalTrials.gov/show/NCT00694382 Completed Sanofi 2010-11-30
NCT00689520 Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT00689520 Completed Hospital Universitari de Bellvitge 2005-01-31
NCT00679588 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery https://ClinicalTrials.gov/show/NCT00679588 Completed Sanofi 2010-08-31
NCT00657150 Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty https://ClinicalTrials.gov/show/NCT00657150 Completed Boehringer Ingelheim 2009-09-30
NCT00641732 Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement https://ClinicalTrials.gov/show/NCT00641732 Completed Takeda 2008-10-31
NCT00634907 Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin) https://ClinicalTrials.gov/show/NCT00634907 Completed University of Utah 2008-10-31
NCT00629447 Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients https://ClinicalTrials.gov/show/NCT00629447 Completed Duke University 2007-03-31
NCT01304108 Improving Venous Thromboembolism Prophylaxis https://ClinicalTrials.gov/show/NCT01304108 Completed Mayo Clinic 2010-05-31
NCT00571649 Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients https://ClinicalTrials.gov/show/NCT00571649 Completed Bayer 2010-08-31
NCT00558259 Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE https://ClinicalTrials.gov/show/NCT00558259 Completed Boehringer Ingelheim 2011-02-28
NCT00556426 Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. https://ClinicalTrials.gov/show/NCT00556426 Completed C. R. Bard 2007-04-30
NCT00531843 The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients https://ClinicalTrials.gov/show/NCT00531843 Completed University of California, San Francisco 2008-06-30
NCT00504556 A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation https://ClinicalTrials.gov/show/NCT00504556 Completed Daiichi Sankyo, Inc. 2008-06-30
NCT00799968 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China https://ClinicalTrials.gov/show/NCT00799968 Completed Beijing Chao Yang Hospital 2006-02-28
NCT00486915 Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence https://ClinicalTrials.gov/show/NCT00486915 Completed London Health Sciences Centre 2008-12-31
NCT00476216 Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00476216 Completed University of Alabama at Birmingham 2012-12-31
NCT00470626 Celect Vena Cava Filter Clinical Trial https://ClinicalTrials.gov/show/NCT00470626 Completed Cook Group Incorporated 2009-03-31
NCT00462852 Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer https://ClinicalTrials.gov/show/NCT00462852 Completed National Cancer Institute (NCI) NA
NCT00451412 A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients https://ClinicalTrials.gov/show/NCT00451412 Completed Novartis 2009-06-30
NCT00439725 Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study https://ClinicalTrials.gov/show/NCT00439725 Completed Bayer 2009-08-31
NCT00432796 PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin. https://ClinicalTrials.gov/show/NCT00432796 Active, not recruiting Lawson Health Research Institute 2019-03-31
NCT00408239 Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement https://ClinicalTrials.gov/show/NCT00408239 Completed Astellas Pharma Inc 2009-03-31
NCT00402467 An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study https://ClinicalTrials.gov/show/NCT00402467 Completed Bayer 2004-11-30
NCT00398905 Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement https://ClinicalTrials.gov/show/NCT00398905 Completed Bayer NA
NCT00396786 Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement https://ClinicalTrials.gov/show/NCT00396786 Completed Bayer 2005-07-31
NCT00395772 Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis https://ClinicalTrials.gov/show/NCT00395772 Completed Bayer NA
NCT00353678 Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2) https://ClinicalTrials.gov/show/NCT00353678 Completed Astellas Pharma Inc 2007-08-31
NCT00381888 Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer https://ClinicalTrials.gov/show/NCT00381888 Completed Masonic Cancer Center, University of Minnesota 2009-01-31
NCT00375609 Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) https://ClinicalTrials.gov/show/NCT00375609 Completed Portola Pharmaceuticals 2007-01-31
NCT00371501 Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00371501 Completed Tuen Mun Hospital 2009-12-31
NCT00362492 Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement https://ClinicalTrials.gov/show/NCT00362492 Completed University Hospital, Caen NA
NCT00362232 Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. https://ClinicalTrials.gov/show/NCT00362232 Completed Bayer 2007-01-31
NCT00361894 Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. https://ClinicalTrials.gov/show/NCT00361894 Completed Bayer 2007-01-31
NCT00361647 Screening for Occult Malignancy in Idiopathic Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00361647 Completed University of Padova 2008-05-31
NCT00338897 Dose Ranging Study in Elective Total Hip Replacement Surgery https://ClinicalTrials.gov/show/NCT00338897 Completed Sanofi 2007-05-31
NCT00333021 Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients https://ClinicalTrials.gov/show/NCT00333021 Completed GlaxoSmithKline NA
NCT00332020 Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement https://ClinicalTrials.gov/show/NCT00332020 Completed Bayer 2007-05-31
NCT00331838 Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00331838 Completed Sanofi 2007-06-30
NCT00329628 Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin https://ClinicalTrials.gov/show/NCT00329628 Completed Bayer 2007-03-31
NCT00329238 Secondary Prevention of Venous Thrombo Embolism (VTE). https://ClinicalTrials.gov/show/NCT00329238 Completed Boehringer Ingelheim 2010-10-31
NCT00328939 ARIXTRA Local Study For Registration In China. https://ClinicalTrials.gov/show/NCT00328939 Completed GlaxoSmithKline NA
NCT00320424 Hip Fracture Study of GSK576428 (Fondaparinux Sodium) https://ClinicalTrials.gov/show/NCT00320424 Completed GlaxoSmithKline 2006-10-26
NCT00320255 A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer https://ClinicalTrials.gov/show/NCT00320255 Completed Bristol-Myers Squibb 2009-01-31
NCT00291330 Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00291330 Completed Boehringer Ingelheim 2009-05-31
NCT00265993 Enoxaparin in Acute Venous Thromboembolic Disease https://ClinicalTrials.gov/show/NCT00265993 Completed Sanofi 2009-01-31
NCT00264277 D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00264277 Completed St. Orsola Hospital 2004-12-31
NCT00260988 A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery https://ClinicalTrials.gov/show/NCT00260988 Completed Ottawa Hospital Research Institute 2008-11-30
NCT00246025 A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery. https://ClinicalTrials.gov/show/NCT00246025 Completed Boehringer Ingelheim 2007-06-30
NCT00244725 Odiparcil For The Prevention Of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00244725 Completed GlaxoSmithKline 2006-09-30
NCT00244426 S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation https://ClinicalTrials.gov/show/NCT00244426 Completed Pfizer 2008-04-30
NCT00219973 CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) https://ClinicalTrials.gov/show/NCT00219973 Completed Rovi Pharmaceuticals Laboratories NA
NCT00205400 Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care https://ClinicalTrials.gov/show/NCT00205400 Completed University of Wisconsin, Madison 2005-03-31
NCT00203658 Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin https://ClinicalTrials.gov/show/NCT00203658 Completed University of Calgary NA
NCT00203580 Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) https://ClinicalTrials.gov/show/NCT00203580 Completed University of Calgary NA
NCT00196118 Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter https://ClinicalTrials.gov/show/NCT00196118 Completed Cook Group Incorporated NA
NCT00182403 Fixed Dose Heparin Study https://ClinicalTrials.gov/show/NCT00182403 Completed McMaster University NA
NCT00182364 PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) https://ClinicalTrials.gov/show/NCT00182364 Completed McMaster University NA
NCT00182221 Safety of a Diagnostic Strategy With D-Dimer Testing for PE https://ClinicalTrials.gov/show/NCT00182221 Completed McMaster University 2008-02-29
NCT00182143 PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) https://ClinicalTrials.gov/show/NCT00182143 Completed McMaster University 2010-06-30
NCT00168818 Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery https://ClinicalTrials.gov/show/NCT00168818 Completed Boehringer Ingelheim 2006-07-31
NCT00168805 RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery https://ClinicalTrials.gov/show/NCT00168805 Completed Boehringer Ingelheim 2006-05-31
NCT00152971 Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement https://ClinicalTrials.gov/show/NCT00152971 Completed Boehringer Ingelheim 2006-06-30
NCT00139815 Michelangelo - Oasis 5 https://ClinicalTrials.gov/show/NCT00139815 Completed GlaxoSmithKline 2005-12-31
NCT00135876 Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients https://ClinicalTrials.gov/show/NCT00135876 Completed Ontario Clinical Oncology Group (OCOG) NA
NCT00119457 Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) https://ClinicalTrials.gov/show/NCT00119457 Completed vTv Therapeutics NA
NCT00077805 PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) https://ClinicalTrials.gov/show/NCT00077805 Completed Sanofi 2006-07-31
NCT00077753 EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization https://ClinicalTrials.gov/show/NCT00077753 Completed Sanofi 2006-10-31
NCT00014352 Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT00014352 Completed Memorial Sloan Kettering Cancer Center 2003-03-31
NCT00064428 OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction https://ClinicalTrials.gov/show/NCT00064428 Completed GlaxoSmithKline 2006-02-28
NCT00071032 Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease https://ClinicalTrials.gov/show/NCT00071032 Completed Rutgers, The State University of New Jersey 2009-05-31
NCT00024297 Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters https://ClinicalTrials.gov/show/NCT00024297 Completed National Cancer Institute (NCI) NA
NCT00020189 Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00020189 Completed National Cancer Institute (NCI) NA
NCT00041509 ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) https://ClinicalTrials.gov/show/NCT00041509 Completed GlaxoSmithKline 2003-05-31
NCT00038961 A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO). https://ClinicalTrials.gov/show/NCT00038961 Completed GlaxoSmithKline 2004-10-31
NCT00796692 Nadroparin for the Initial Treatment of Pulmonary Thromboembolism https://ClinicalTrials.gov/show/NCT00796692 Completed Beijing Chao Yang Hospital 2006-02-28
NCT00007085 Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II) https://ClinicalTrials.gov/show/NCT00007085 Completed National Heart, Lung, and Blood Institute (NHLBI) 2004-12-31
NCT00000614 Prevention of Recurrent Venous Thromboembolism (PREVENT) https://ClinicalTrials.gov/show/NCT00000614 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04349189 Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait https://ClinicalTrials.gov/show/NCT04349189 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-15
NCT03897478 Biomarkers of Acute Stroke in Clinic https://ClinicalTrials.gov/show/NCT03897478 Recruiting Ischemia Care LLC 2022-12-31
NCT03407469 Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization https://ClinicalTrials.gov/show/NCT03407469 Recruiting M.D. Anderson Cancer Center 2019-12-31
NCT03405571 Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias. https://ClinicalTrials.gov/show/NCT03405571 Recruiting University of Athens 2020-06-30
NCT03381963 Hemostatic Profiles of Endocrine Therapies for Breast Cancer https://ClinicalTrials.gov/show/NCT03381963 Completed University Hospital, Geneva 2020-02-28
NCT01366599 CV Events in Emetogenic Chemotherapy https://ClinicalTrials.gov/show/NCT01366599 Completed GlaxoSmithKline 2009-07-31
NCT03359889 PraxbindTM India PMS Program https://ClinicalTrials.gov/show/NCT03359889 Completed Boehringer Ingelheim 2020-01-13
NCT03292666 Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study https://ClinicalTrials.gov/show/NCT03292666 Recruiting University of California, San Francisco 2020-12-31
NCT03282747 Distribution of Risk Factors for Venous Thromboembolism in Blood Donors https://ClinicalTrials.gov/show/NCT03282747 Completed Casa Sollievo della Sofferenza IRCCS 2018-07-15
NCT03214172 Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban https://ClinicalTrials.gov/show/NCT03214172 Completed Bayer 2017-09-15
NCT03206372 Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure https://ClinicalTrials.gov/show/NCT03206372 Recruiting University Hospital, Brest 2020-10-24
NCT03141749 Venous Thromboembolism in DM1 https://ClinicalTrials.gov/show/NCT03141749 Completed Institut de Myologie, France 2014-11-30
NCT03134898 Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03134898 Recruiting Sociedad Española de Neumología y Cirugía Torácica 2019-06-30
NCT03134820 Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease https://ClinicalTrials.gov/show/NCT03134820 Completed Delos Clinical 2016-12-31
NCT03115541 Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection https://ClinicalTrials.gov/show/NCT03115541 Recruiting McMaster University 2019-12-30
NCT03114618 A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient https://ClinicalTrials.gov/show/NCT03114618 Completed Hospital General Universitario Gregorio Marañon 2016-11-30
NCT03099031 Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT03099031 Completed LEO Pharma 2017-05-15
NCT03087474 Treatment of Venous Thromboembolism in Real-Life Patients https://ClinicalTrials.gov/show/NCT03087474 Completed Bristol-Myers Squibb 2017-12-31
NCT03068923 Thrombosis Outcomes in Pediatric Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03068923 Active, not recruiting University of Texas Southwestern Medical Center 2022-02-28
NCT03041805 Caprini Score in Venous Surgery: a Prospective Cohort Study https://ClinicalTrials.gov/show/NCT03041805 Recruiting Pirogov Russian National Research Medical University 2025-01-01
NCT03031457 Microsurgical Breast Reconstruction & VTE https://ClinicalTrials.gov/show/NCT03031457 Completed Stanford University 2017-12-15
NCT03025100 VTE Prophylaxis Guidelines in Hospitalized Elders https://ClinicalTrials.gov/show/NCT03025100 Completed Duke University 2017-03-04
NCT02955004 Electrical Cardioversion of Recent Onset Atrial Fibrillation - Silent Thromboembolic Events, Reverse Atrial Remodeling https://ClinicalTrials.gov/show/NCT02955004 Completed Uppsala University Hospital 2017-11-30
NCT02952599 Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN) https://ClinicalTrials.gov/show/NCT02952599 Completed Daiichi Sankyo, Inc. 2019-10-29
NCT02943993 Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe https://ClinicalTrials.gov/show/NCT02943993 Active, not recruiting Daiichi Sankyo, Inc. 2020-11-30
NCT02935751 Apixaban Discontinuation Prior to Major Surgery https://ClinicalTrials.gov/show/NCT02935751 Completed Thomas Jefferson University 2018-07-31
NCT02898090 Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions https://ClinicalTrials.gov/show/NCT02898090 Recruiting University Hospital, Bordeaux 2020-04-30
NCT02895971 Incidence of Venous Thromboembolism and Professional Practices in Brest Area https://ClinicalTrials.gov/show/NCT02895971 Completed University Hospital, Brest 2017-06-30
NCT02828904 RIVET-Case Control Study https://ClinicalTrials.gov/show/NCT02828904 Recruiting Center for Epidemiology and Health Research, Germany 2021-03-31
NCT02742623 A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer https://ClinicalTrials.gov/show/NCT02742623 Completed Bayer 2018-11-30
NCT02739867 Tumor-educated Platelets in Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02739867 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2020-07-31
NCT02696447 Radiation Impact on Thromboembolic Events https://ClinicalTrials.gov/show/NCT02696447 Completed Institut de Cancérologie de la Loire 2018-12-24
NCT02661568 Description of Patients With Acute Venous Thromboembolism in the UK’s Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES) https://ClinicalTrials.gov/show/NCT02661568 Completed Bristol-Myers Squibb 2015-12-31
NCT02597218 Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study. https://ClinicalTrials.gov/show/NCT02597218 Recruiting Hospital Italiano de Buenos Aires 2019-10-31
NCT02596230 RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02596230 Completed Boehringer Ingelheim 2019-03-31
NCT02584842 Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy https://ClinicalTrials.gov/show/NCT02584842 Completed University Hospital, Basel, Switzerland 2014-12-31
NCT02964208 AMPLATZERâ„¢ LAA Occluder Post Approval Study (PAS) https://ClinicalTrials.gov/show/NCT02964208 Recruiting Abbott Medical Devices 2023-10-31
NCT03404635 Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03404635 Recruiting Indiana University 2020-12-31
NCT02558465 Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT02558465 Active, not recruiting Bayer 2020-04-01
NCT02552420 The Clinical Application of Infrared Thermal Imaging Detecting Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02552420 Completed The First Affiliated Hospital of Guangzhou Medical University 2012-07-31
NCT02480790 Venous Thromboembolic Complications in Ovarian Cancer https://ClinicalTrials.gov/show/NCT02480790 Active, not recruiting Aalborg University Hospital 2017-05-31
NCT02443610 Haemorrhages and Thromboembolic Venous Disease of the Postpartum https://ClinicalTrials.gov/show/NCT02443610 Recruiting University Hospital, Brest 2019-02-28
NCT02407717 Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer https://ClinicalTrials.gov/show/NCT02407717 Completed G. d’Annunzio University 2017-08-31
NCT02319460 An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding https://ClinicalTrials.gov/show/NCT02319460 Recruiting CSL Behring 2023-03-15
NCT02297373 Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) https://ClinicalTrials.gov/show/NCT02297373 Active, not recruiting Ottawa Hospital Research Institute 2019-01-03
NCT02268630 Long Term Outcomes of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02268630 Recruiting Ostfold Hospital Trust 2023-10-31
NCT02210819 Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy https://ClinicalTrials.gov/show/NCT02210819 Completed Bayer 2016-11-03
NCT02156401 VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE https://ClinicalTrials.gov/show/NCT02156401 Recruiting Johannes Gutenberg University Mainz 2023-07-31
NCT01303523 Evaluation of the Prevention of Thromboembolic Disease in Patients With a Lower Limb Trauma, Non Surgical, in Winter Sports Resort https://ClinicalTrials.gov/show/NCT01303523 Completed Floralis 2011-03-31
NCT01297348 Study Of Lybrel In Relation To Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01297348 Completed Pfizer 2012-04-30
NCT01277536 Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland https://ClinicalTrials.gov/show/NCT01277536 Completed University Hospital, Geneva 2011-11-30
NCT02052544 Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device https://ClinicalTrials.gov/show/NCT02052544 Completed DSM Nutritional Products, Inc. 2013-05-31
NCT02037607 Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures https://ClinicalTrials.gov/show/NCT02037607 Completed Indiana University 2015-07-31
NCT01958203 Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines. https://ClinicalTrials.gov/show/NCT01958203 Completed Ministry of Health, United Arab Emirates 2013-08-31
NCT01885585 Eliquis Regulatory Post Marketing Surveillance (rPMS) https://ClinicalTrials.gov/show/NCT01885585 Completed Bristol-Myers Squibb 2015-05-31
NCT01855698 PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01855698 Completed Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-03-15
NCT01851239 Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital https://ClinicalTrials.gov/show/NCT01851239 Completed Yonsei University 2013-07-31
NCT01809015 Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme https://ClinicalTrials.gov/show/NCT01809015 Completed Johannes Gutenberg University Mainz 2018-03-31
NCT01803022 Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer https://ClinicalTrials.gov/show/NCT01803022 Completed LEO Pharma 2013-07-31
NCT01781858 Study on the Clinical Course Of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01781858 Completed University of Padova 2014-05-31
NCT01715779 Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies https://ClinicalTrials.gov/show/NCT01715779 Completed Novartis 2015-06-30
NCT01619007 Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy https://ClinicalTrials.gov/show/NCT01619007 Completed Bayer 2015-03-31
NCT01602445 Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01602445 Completed Ottawa Hospital Research Institute 2016-10-31
NCT01602432 Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients https://ClinicalTrials.gov/show/NCT01602432 Completed Ottawa Hospital Research Institute 2013-08-31
NCT01580085 Obstructive Sleep Apnea in Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01580085 Completed University of Gaziantep 2010-12-31
NCT01559207 Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01559207 Completed Centre Hospitalier Universitaire de Nīmes 2014-10-31
NCT01557725 Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty. https://ClinicalTrials.gov/show/NCT01557725 Completed Rigshospitalet, Denmark 2013-05-31
NCT01541995 Evaluation of Contrast Medium Enhanced Post-mortem CT in Virtual Autopsy https://ClinicalTrials.gov/show/NCT01541995 Completed Universitätsklinikum Hamburg-Eppendorf 2013-08-31
NCT01524393 Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilization https://ClinicalTrials.gov/show/NCT01524393 Completed Danderyd Hospital 2008-12-31
NCT01492777 Pharmacogenetics of Acenocoumarol https://ClinicalTrials.gov/show/NCT01492777 Completed University Hospital, Geneva 2011-03-31
NCT01466426 The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study) https://ClinicalTrials.gov/show/NCT01466426 Completed Odense University Hospital 2013-12-31
NCT01428544 Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) https://ClinicalTrials.gov/show/NCT01428544 Completed GlaxoSmithKline 2015-06-30
NCT01428531 Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment https://ClinicalTrials.gov/show/NCT01428531 Completed GlaxoSmithKline 2015-06-30
NCT01420809 Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection https://ClinicalTrials.gov/show/NCT01420809 Completed GlaxoSmithKline 2009-05-31
NCT01372514 Institutional Registry of Thromboembolic Disease https://ClinicalTrials.gov/show/NCT01372514 Recruiting Hospital Italiano de Buenos Aires 2020-01-31
NCT01362933 National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients https://ClinicalTrials.gov/show/NCT01362933 Completed Floralis 2012-01-31
NCT01345773 Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer https://ClinicalTrials.gov/show/NCT01345773 Completed Seoul National University Bundang Hospital 2011-09-30
NCT04446325 Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis https://ClinicalTrials.gov/show/NCT04446325 Recruiting University Hospital, Brest 2020-09-01
NCT04405869 Thromboembolic Events in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04405869 Recruiting University Hospital, Strasbourg, France 2021-04-30
NCT04377490 Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04377490 Recruiting Centre Hospitalier Universitaire, Amiens 2020-10-31
NCT04374617 Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04374617 Completed Hospital Universitari Vall d’Hebron Research Institute 2020-04-25
NCT04366752 Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy https://ClinicalTrials.gov/show/NCT04366752 Recruiting Centre Hospitalier Universitaire, Amiens 2020-08-22
NCT04335162 Cardiovascular Complications and COVID-19 (CovCardioVasc) https://ClinicalTrials.gov/show/NCT04335162 Recruiting Centre Hospitalier Universitaire de Nice 2020-08-28
NCT04301362 Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients https://ClinicalTrials.gov/show/NCT04301362 Recruiting Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. 2021-07-19
NCT04294589 Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events https://ClinicalTrials.gov/show/NCT04294589 Recruiting Assistance Publique - Hôpitaux de Paris 2020-07-31
NCT04179487 The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety Study https://ClinicalTrials.gov/show/NCT04179487 Recruiting University College Dublin 2023-12-31
NCT04141228 A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US https://ClinicalTrials.gov/show/NCT04141228 Completed Bristol-Myers Squibb 2018-04-30
NCT04130048 Thrombus Elastography in Venous Thrombo-Embolism. https://ClinicalTrials.gov/show/NCT04130048 Recruiting University Hospital, Brest 2019-12-14
NCT04122430 Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours - a Multi-Site Retrospective Cohort Study as Part of the Global Germ-Cell Cancer Group (G3) Consortium https://ClinicalTrials.gov/show/NCT04122430 Active, not recruiting Walter and Eliza Hall Institute of Medical Research 2019-12-31
NCT04117217 Risk Factors for Thrombosis in Children With Central Venous Lines https://ClinicalTrials.gov/show/NCT04117217 Recruiting University of Arizona 2023-12-31
NCT04115436 Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation https://ClinicalTrials.gov/show/NCT04115436 Recruiting Texas Cardiac Arrhythmia Research Foundation 2020-10-01
NCT04007653 Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE https://ClinicalTrials.gov/show/NCT04007653 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2020-12-31
NCT03965741 Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners https://ClinicalTrials.gov/show/NCT03965741 Active, not recruiting Bayer 2020-07-31
NCT03949985 Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives https://ClinicalTrials.gov/show/NCT03949985 Recruiting University Hospital, Geneva 2020-12-31
NCT03914053 Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General Medicine https://ClinicalTrials.gov/show/NCT03914053 Completed University Hospital, Montpellier 2018-09-01
NCT03894878 Association Between Genetic Variant Scores and Warfarin Effect https://ClinicalTrials.gov/show/NCT03894878 Recruiting Cipherome, Inc. 2021-03-12
NCT03893461 Coagulation System In STereotactic Radiotherapy Of NSCLC https://ClinicalTrials.gov/show/NCT03893461 Recruiting Odense University Hospital 2020-12-31
NCT03887806 Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study https://ClinicalTrials.gov/show/NCT03887806 Recruiting University Hospital, Strasbourg, France 2020-03-20
NCT03877770 DVT After Cardiac Procedure https://ClinicalTrials.gov/show/NCT03877770 Completed Manchester University NHS Foundation Trust 2019-07-31
NCT03855592 Registry of Thrombosis & NEoplasia of “Sociedad Española de Oncología Médica” https://ClinicalTrials.gov/show/NCT03855592 Recruiting Fundación Sociedad Española de Oncologia Médica 2020-07-31
NCT03835780 The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study https://ClinicalTrials.gov/show/NCT03835780 Completed Momentum Data 2019-08-01
NCT03802929 Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03802929 Recruiting Shanghai 10th People’s Hospital 2024-12-31
NCT03799016 An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwan https://ClinicalTrials.gov/show/NCT03799016 Completed Bayer 2017-07-01
NCT03781531 Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03781531 Recruiting Danderyd Hospital 2022-12-31
NCT03646409 Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer https://ClinicalTrials.gov/show/NCT03646409 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2018-10-01
NCT03595891 The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung https://ClinicalTrials.gov/show/NCT03595891 Active, not recruiting Bristol-Myers Squibb 2018-12-28
NCT03535428 Venous Thrombo-embolic Complication prévention in Pelvic Surgery https://ClinicalTrials.gov/show/NCT03535428 Completed Groupe Hospitalier Paris Saint Joseph 2018-04-25
NCT03535090 Coagulation After Intravenous Methylprednisolone Administration https://ClinicalTrials.gov/show/NCT03535090 Completed Medical University of Warsaw 2014-12-31
NCT03477968 ThRombosis ExclUsion STudy https://ClinicalTrials.gov/show/NCT03477968 Recruiting Diagnostica Stago 2020-09-30
NCT03475771 Retrospective Evaluation of Thrombo-embolic Complication in Pelvic Fracture Surgery https://ClinicalTrials.gov/show/NCT03475771 Completed Groupe Hospitalier Paris Saint Joseph 2017-12-31
NCT01221805 STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01221805 Completed Diagnostica Stago 2016-03-31
NCT01212393 Prevention of Venous Thromboembolism Disease in Emergency Departments https://ClinicalTrials.gov/show/NCT01212393 Completed University Hospital, Angers 2011-03-31
NCT01206751 Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation https://ClinicalTrials.gov/show/NCT01206751 Completed Taipei Medical University WanFang Hospital 2010-05-31
NCT01176305 Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005 https://ClinicalTrials.gov/show/NCT01176305 Completed Hillerod Hospital, Denmark NA
NCT01158482 Filter Initial & Long Term Evaluation After Placement and Retrieval Registry https://ClinicalTrials.gov/show/NCT01158482 Recruiting Stanford University 2025-06-30
NCT01140386 Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric Patients https://ClinicalTrials.gov/show/NCT01140386 Completed Penn State University 2010-03-31
NCT01139658 Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA https://ClinicalTrials.gov/show/NCT01139658 Completed Boehringer Ingelheim 2012-09-30
NCT01132833 Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT01132833 Completed UNC Lineberger Comprehensive Cancer Center 2012-12-31
NCT01102933 RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients https://ClinicalTrials.gov/show/NCT01102933 Completed Uppsala University 2012-08-31
NCT01047618 Venous Thromboembolism in Advanced Gastric Cancer Patients https://ClinicalTrials.gov/show/NCT01047618 Completed Asan Medical Center 2014-12-31
NCT01046903 An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin® https://ClinicalTrials.gov/show/NCT01046903 Completed Pfizer 2011-02-28
NCT01029743 Xarelto Regulatory Post-Marketing Surveillance https://ClinicalTrials.gov/show/NCT01029743 Completed Bayer 2015-03-31
NCT01004939 Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01004939 Completed GlaxoSmithKline 2010-07-31
NCT00973596 The Swiss Venous Thromboembolism Cohort 65+ https://ClinicalTrials.gov/show/NCT00973596 Completed University of Lausanne Hospitals 2012-03-31
NCT00954395 DULCIS (D-dimer and ULtrasonography in Combination Italian Study) https://ClinicalTrials.gov/show/NCT00954395 Completed St. Orsola Hospital 2011-12-31
NCT00925808 Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans https://ClinicalTrials.gov/show/NCT00925808 Active, not recruiting M.D. Anderson Cancer Center 2020-06-30
NCT00911001 SALTO - Epidemiological Study on Compliance and Treatment Satisfaction https://ClinicalTrials.gov/show/NCT00911001 Completed Bayer 2009-03-31
NCT00856076 Venous Thromboembolism in Pregnancy Study https://ClinicalTrials.gov/show/NCT00856076 Recruiting Oslo University Hospital 2010-12-31
NCT00847301 Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00847301 Completed Boehringer Ingelheim 2014-07-31
NCT00846807 Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00846807 Completed Boehringer Ingelheim 2011-07-31
NCT00831714 Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty https://ClinicalTrials.gov/show/NCT00831714 Completed Bayer 2011-06-30
NCT00830570 The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings https://ClinicalTrials.gov/show/NCT00830570 Completed Medco Health Solutions, Inc. 2010-01-31
NCT04412304 Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients https://ClinicalTrials.gov/show/NCT04412304 Completed Karolinska Institutet 2020-04-30
NCT04257305 Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical Inpatients https://ClinicalTrials.gov/show/NCT04257305 Completed Huashan Hospital 2019-12-31
NCT00810784 Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients https://ClinicalTrials.gov/show/NCT00810784 Completed University of Utah 2007-03-31
NCT04400877 Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400877 Recruiting University Hospital, Linkoeping 2020-06-19
NCT02713581 IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02713581 Completed Centre Hospitalier Universitaire de Nīmes 2019-01-03
NCT03870464 LIFE - Lung Cancer, Immunotherapy, Frailty, Effect https://ClinicalTrials.gov/show/NCT03870464 Recruiting University of Southern Denmark 2021-09-30
NCT02502396 Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center https://ClinicalTrials.gov/show/NCT02502396 Active, not recruiting M.D. Anderson Cancer Center 2020-09-30
NCT03773939 Risk Prediction of Venous Thromboembolism in Critically Ill https://ClinicalTrials.gov/show/NCT03773939 Recruiting University Medical Center Groningen 2021-05-01
NCT00788736 Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00788736 Completed Ottawa Hospital Research Institute 2016-09-30
NCT00755300 Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical Techniques https://ClinicalTrials.gov/show/NCT00755300 Completed University of California, Davis 2008-06-30
NCT00745212 Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women https://ClinicalTrials.gov/show/NCT00745212 Completed Centre Hospitalier Universitaire de Saint Etienne 2012-12-31
NCT00695942 Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease https://ClinicalTrials.gov/show/NCT00695942 Completed Centre Hospitalier Universitaire de Saint Etienne 2012-05-31
NCT00683397 Frankfurt Thrombophilia Registry https://ClinicalTrials.gov/show/NCT00683397 Completed Cardioangiologisches Centrum Bethanien 2014-12-31
NCT00676065 Long-term Active Surveillance Study for Oral Contraceptives (LASS) https://ClinicalTrials.gov/show/NCT00676065 Completed Center for Epidemiology and Health Research, Germany 2011-03-31
NCT00660205 Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00660205 Completed University of Aarhus 2011-02-28
NCT00631423 Evaluation of Patients With Vena Cava Inferior Thrombosis https://ClinicalTrials.gov/show/NCT00631423 Completed Johann Wolfgang Goethe University Hospital 2014-04-30
NCT00604370 Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge https://ClinicalTrials.gov/show/NCT00604370 Completed Brigham and Women’s Hospital 2010-02-28
NCT00535171 Venous Thromboembolism Taskforce Audit Program https://ClinicalTrials.gov/show/NCT00535171 Completed Sanofi 2008-08-31
NCT00523614 Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00523614 Completed Center for Epidemiology and Health Research, Germany NA
NCT00511784 Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives. https://ClinicalTrials.gov/show/NCT00511784 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2007-06-30
NCT00456196 Epidemiology of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00456196 Completed Brigham and Women’s Hospital 2009-06-30
NCT00433602 Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors https://ClinicalTrials.gov/show/NCT00433602 Completed European Organisation for Research and Treatment of Cancer - EORTC 2007-03-31
NCT00377988 A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control https://ClinicalTrials.gov/show/NCT00377988 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2008-10-31
NCT00331071 Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks https://ClinicalTrials.gov/show/NCT00331071 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2006-03-31
NCT00266045 D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence https://ClinicalTrials.gov/show/NCT00266045 Completed St. Orsola Hospital 2008-06-30
NCT00253669 Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas https://ClinicalTrials.gov/show/NCT00253669 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2009-08-31
NCT02833987 Direct Oral Anticoagulants and Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02833987 Completed Canadian Network for Observational Drug Effect Studies, CNODES 2015-03-31
NCT00201903 The Roles of Tissue Factor in Malignant Gliomas https://ClinicalTrials.gov/show/NCT00201903 Completed Ontario Clinical Oncology Group (OCOG) NA
NCT00096590 Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery https://ClinicalTrials.gov/show/NCT00096590 Completed National Cancer Institute (NCI) NA
NCT00094185 Clotting Genetic Variants, Hormones, and Venous Thrombosis https://ClinicalTrials.gov/show/NCT00094185 Completed University of Washington 2009-03-31
NCT00004875 Heparin or Enoxaparin in Patients With Cancer https://ClinicalTrials.gov/show/NCT00004875 Completed Northwestern University 1999-03-31
NCT00063518 Monitoring Trends in Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00063518 Completed University of Massachusetts, Worcester 2007-12-31
NCT00041457 Epidemiology of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00041457 Completed Brigham and Women’s Hospital 2006-06-30
NCT00266994 HTRS TE Registry (ThromboEmbolism Registry) https://ClinicalTrials.gov/show/NCT00266994 Completed Nationwide Children’s Hospital 2012-10-31
NCT00011180 Risk Factors for Venous Thromboembolism in the Community https://ClinicalTrials.gov/show/NCT00011180 Completed Mayo Clinic 2009-05-31
NCT00005684 Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis https://ClinicalTrials.gov/show/NCT00005684 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005543 Genetic Epidemiology of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00005543 Completed Mayo Clinic 2005-06-30
NCT00005515 Mutations, Hormone Therapy (HRT) and Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00005515 Completed University of Washington NA
NCT00005496 Inflammation, Infection, and Future Cardiovascular Risk https://ClinicalTrials.gov/show/NCT00005496 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00005351 Incidence and Outcomes of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00005351 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03185377 Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China https://ClinicalTrials.gov/show/NCT03185377 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-12-31
NCT03073915 Evaluation of the Risk of VTE Among Patients Hospitalized in Non-surgical Departments https://ClinicalTrials.gov/show/NCT03073915 Active, not recruiting Hadassah Medical Organization 2020-12-31
NCT02950168 Edoxaban Management in Diagnostic and Therapeutic Procedures https://ClinicalTrials.gov/show/NCT02950168 Completed Daiichi Sankyo, Inc. 2018-07-26
NCT02943343 The China Pulmonary Thromboembolism Registry Study https://ClinicalTrials.gov/show/NCT02943343 Recruiting China-Japan Friendship Hospital 2019-12-31
NCT02832245 Computerized Registry of Patients With Venous Thromboembolism (RIETE) https://ClinicalTrials.gov/show/NCT02832245 Recruiting Foundation for the study of VTE diseases. (FUENTE) 2026-12-31
NCT02546817 Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS https://ClinicalTrials.gov/show/NCT02546817 Completed Bristol-Myers Squibb 2017-09-29
NCT02461602 Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients https://ClinicalTrials.gov/show/NCT02461602 Completed Duke University 2018-05-31
NCT02447081 Amplatzerâ„¢Amuletâ„¢ Post-Market Study (Amuletâ„¢PMS) https://ClinicalTrials.gov/show/NCT02447081 Completed Abbott Medical Devices 2018-10-23
NCT02219984 START-Register: Survey on Anticoagulated Patients Register https://ClinicalTrials.gov/show/NCT02219984 Recruiting St. Orsola Hospital 2023-07-31
NCT02213978 A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients https://ClinicalTrials.gov/show/NCT02213978 Recruiting Beijing Chao Yang Hospital 2020-01-31
NCT02155491 Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events https://ClinicalTrials.gov/show/NCT02155491 Active, not recruiting Thrombosis Research Institute 2020-01-04
NCT02079584 Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant https://ClinicalTrials.gov/show/NCT02079584 Recruiting Indiana University 2020-03-31
NCT01984190 Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.T® Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty https://ClinicalTrials.gov/show/NCT01984190 Completed Medical Compression Systems 2011-10-31
NCT01972282 Registry on WATCHMAN Outcomes in Real-Life Utilization https://ClinicalTrials.gov/show/NCT01972282 Completed Boston Scientific Corporation 2015-11-30
NCT01774357 Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems https://ClinicalTrials.gov/show/NCT01774357 Completed Biotronik SE & Co. KG 2018-09-30
NCT01744431 Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients https://ClinicalTrials.gov/show/NCT01744431 Completed HaEmek Medical Center, Israel 2013-09-30
NCT04414332 Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry https://ClinicalTrials.gov/show/NCT04414332 Completed University of California, Los Angeles 2020-02-27
NCT04394000 Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 https://ClinicalTrials.gov/show/NCT04394000 Completed Jessa Hospital 2020-05-15
NCT04246073 Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism https://ClinicalTrials.gov/show/NCT04246073 Recruiting Hellenic Society of Surgical Oncology 2020-02-01
NCT04195113 Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry https://ClinicalTrials.gov/show/NCT04195113 Recruiting McMaster University 2022-08-31
NCT04124159 Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism https://ClinicalTrials.gov/show/NCT04124159 Recruiting Medical University of Vienna 2023-12-31
NCT04042155 Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD) https://ClinicalTrials.gov/show/NCT04042155 Recruiting Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2022-08-01
NCT03881345 Ongoing Registry of Treatment of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03881345 Recruiting Medalp Private Surgery Clinic 2036-03-01
NCT03854149 A Prospective Study on the Safety and Efficacy of Apixaban for the PReventiOn of ThromboEmbolism in Adults With Congenital HearΤ Disease and Atrial ARrhythmias https://ClinicalTrials.gov/show/NCT03854149 Recruiting AHEPA University Hospital 2022-06-30
NCT03761173 FlowTriever All-Comer Registry for Patient Safety and Hemodynamics https://ClinicalTrials.gov/show/NCT03761173 Enrolling by invitation Inari Medical 2020-12-31
NCT03660007 Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer https://ClinicalTrials.gov/show/NCT03660007 Completed Karolinska Institutet 2012-12-31
NCT03591627 Left Atrial Thrombus on Transesophageal Echocardiography https://ClinicalTrials.gov/show/NCT03591627 Recruiting Medical University of Warsaw 2019-09-30